Lista de obras - Rebecca B Riggins - Dominio Público Uruguay

Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation

artículo científico publicado en 2015

Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma.

artículo científico publicado en 2018

Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer

artículo científico publicado en 2005

Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer

artículo científico publicado en 2016

BCL2 and CASP8 regulation by NF-kappaB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells.

artículo científico publicado en 2010

Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling

artículo científico publicado en 2007

Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosis

artículo científico publicado en 2010

Differential prioritization of therapies to subtypes of triple negative breast cancer using a systems medicine method

artículo científico publicado en 2017

ERK/MAPK regulates ERRγ expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer

artículo científico publicado en 2014

ERRβ splice variants differentially regulate cell cycle progression.

artículo científico publicado en 2015

ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer

artículo científico publicado en 2015

Endoplasmic reticulum stress, the unfolded protein response, and gene network modeling in antiestrogen resistant breast cancer

artículo científico publicado en 2011

Functions of the adapter protein Cas: signal convergence and the determination of cellular responses

artículo científico publicado en 2001

G-DOC: a systems medicine platform for personalized oncology

artículo científico publicado en 2011

Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells

artículo científico publicado en 2009

Human X-box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines.

artículo científico publicado en 2007

IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis

artículo científico publicado en 2010

Identification of condition-specific regulatory modules through multi-level motif and mRNA expression analysis.

artículo científico publicado en 2009

Identifying cancer biomarkers by network-constrained support vector machines

artículo científico publicado en 2011

Identifying protein interaction subnetworks by a bagging Markov random field-based method.

artículo científico publicado en 2012

In Silico Discovery of Mitosis Regulation Networks Associated with Early Distant Metastases in Estrogen Receptor Positive Breast Cancers ⬇️

artículo científico publicado el 13 de febrero de 2013

Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities

artículo científico publicado en 2017

Interferon regulatory factor-1 signaling regulates the switch between autophagy and apoptosis to determine breast cancer cell fate

artículo científico publicado en 2015

Motif-guided sparse decomposition of gene expression data for regulatory module identification

artículo científico publicado en 2011

Multilevel support vector regression analysis to identify condition-specific regulatory networks

artículo científico publicado en 2010

NF-κB signaling is required for XBP1 (unspliced and spliced)-mediated effects on antiestrogen responsiveness and cell fate decisions in breast cancer

artículo científico publicado en 2014

Nutritional modulation of the cell cycle and breast cancer.

artículo científico publicado en 2004

Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response.

artículo científico publicado en 2010

Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b.

artículo científico publicado en 2006

Reconstruction of transcriptional regulatory networks by stability-based network component analysis.

artículo científico publicado en 2013

Robust identification of transcriptional regulatory networks using a Gibbs sampler on outlier sum statistic

artículo científico publicado en 2014

Synergistic promotion of c-Src activation and cell migration by Cas and AND-34/BCAR3.

artículo científico publicado en 2003

The A4396G polymorphism in interferon regulatory factor 1 is frequently expressed in breast cancer cell lines.

artículo científico publicado en 2007

The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer.

artículo científico publicado en 2018

The proapoptotic molecule BLID interacts with Bcl-XL and its downregulation in breast cancer correlates with poor disease-free and overall survival.

artículo científico publicado en 2010

The role of X-box binding protein-1 in tumorigenicity.

artículo científico publicado en 2009

Trans-resveratrol boronic acid exhibits enhanced anti-proliferative activity on estrogen-dependent MCF-7 breast cancer cells

artículo científico publicado en 2012

interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant).

artículo científico publicado en 2004

Lista de obras de Rebecca B Riggins

Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation

Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma.

Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer

Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer

BCL2 and CASP8 regulation by NF-kappaB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells.

Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling

Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosis

Differential prioritization of therapies to subtypes of triple negative breast cancer using a systems medicine method

ERK/MAPK regulates ERRγ expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer

ERRβ splice variants differentially regulate cell cycle progression.

ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer

Endoplasmic reticulum stress, the unfolded protein response, and gene network modeling in antiestrogen resistant breast cancer

Functions of the adapter protein Cas: signal convergence and the determination of cellular responses

G-DOC: a systems medicine platform for personalized oncology

Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells

Human X-box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines.

IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis

Identification of condition-specific regulatory modules through multi-level motif and mRNA expression analysis.

Identifying cancer biomarkers by network-constrained support vector machines

Identifying protein interaction subnetworks by a bagging Markov random field-based method.

In Silico Discovery of Mitosis Regulation Networks Associated with Early Distant Metastases in Estrogen Receptor Positive Breast Cancers ⬇️

Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities

Interferon regulatory factor-1 signaling regulates the switch between autophagy and apoptosis to determine breast cancer cell fate

Motif-guided sparse decomposition of gene expression data for regulatory module identification

Multilevel support vector regression analysis to identify condition-specific regulatory networks

NF-κB signaling is required for XBP1 (unspliced and spliced)-mediated effects on antiestrogen responsiveness and cell fate decisions in breast cancer

Nutritional modulation of the cell cycle and breast cancer.

Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response.

Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b.

Reconstruction of transcriptional regulatory networks by stability-based network component analysis.

Robust identification of transcriptional regulatory networks using a Gibbs sampler on outlier sum statistic

Synergistic promotion of c-Src activation and cell migration by Cas and AND-34/BCAR3.

The A4396G polymorphism in interferon regulatory factor 1 is frequently expressed in breast cancer cell lines.

The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer.

The proapoptotic molecule BLID interacts with Bcl-XL and its downregulation in breast cancer correlates with poor disease-free and overall survival.

The role of X-box binding protein-1 in tumorigenicity.

Trans-resveratrol boronic acid exhibits enhanced anti-proliferative activity on estrogen-dependent MCF-7 breast cancer cells

interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant).